These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 26340897

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F, Coutinho L, Fleming C, Magalhães M, Oliveira V, Rodrigues-Pinto R, Cardoso P.
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
    Akeda K, Kasai Y, Sakakibara T, Matsumine A, Takegami N, Yamada J, Sudo A.
    Spine (Phila Pa 1976); 2015 May 15; 40(10):E601-8. PubMed ID: 25955096
    [Abstract] [Full Text] [Related]

  • 25. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.
    Marinova VV, Slavchev SA, Patrikov KD, Tsenova PM, Georgiev GP.
    Folia Med (Plovdiv); 2018 Dec 01; 60(4):637-640. PubMed ID: 31188771
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW.
    JBJS Case Connect; 2016 Dec 01; 6(3):e74. PubMed ID: 29252651
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combining two-stage surgery and denosumab treatment in a patient with giant cell tumour of the lumbar spine with intraperitoneal growth.
    Liu S, Zhou X, Song A, Huo Z, Wang Y, Liu Y.
    Postgrad Med J; 2019 Feb 01; 95(1120):106-107. PubMed ID: 30425137
    [No Abstract] [Full Text] [Related]

  • 32. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.
    Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M.
    J Bone Joint Surg Am; 2014 Aug 06; 96(15):e127. PubMed ID: 25100780
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Metaphyseal sclerosis in a child with a giant cell tumour treated with denosumab.
    Szymczuk V, Boyce A, Merchant N.
    Lancet; 2023 Jul 15; 402(10397):e4. PubMed ID: 37453752
    [No Abstract] [Full Text] [Related]

  • 35. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
    Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE.
    Am J Surg Pathol; 2021 Jan 15; 45(1):93-100. PubMed ID: 32773532
    [Abstract] [Full Text] [Related]

  • 36. Denosumab for an inoperable giant cell tumour of the ischial bone.
    Paul AG, See LP, Ohn MH, Ohn KM.
    BMJ Case Rep; 2023 Dec 18; 16(12):. PubMed ID: 38110341
    [Abstract] [Full Text] [Related]

  • 37. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A.
    J Clin Pathol; 2016 Mar 18; 69(3):240-7. PubMed ID: 26338802
    [Abstract] [Full Text] [Related]

  • 38. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
    Yonezawa N, Murakami H, Demura S, Kato S, Yoshioka K, Takeuchi A, Shinmura K, Yokogawa N, Shimizu T, Oku N, Kitagawa R, Handa M, Tsuchiya H.
    World Neurosurg; 2019 Jul 18; 127():38-46. PubMed ID: 30926552
    [Abstract] [Full Text] [Related]

  • 39. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
    Tsukamoto S, Mavrogenis AF, Leone G, Righi A, Akahane M, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C.
    Int Orthop; 2019 Feb 18; 43(2):483-489. PubMed ID: 30099641
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.